Screening for type 2 diabetes: a short report for the National Screening Committee.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Health Technology Assessment

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3310/hta17350PMID 23972041PMCID PMC4780946
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A four‐stage model explaining the higher risk of Type 2 diabetes mellitus in South Asians compared with European populations

  2013cited by this paper
• Changes in physical activity and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort

  2013cited by this paper
• An evaluation of the performance of the NHS Health Check programme in identifying people at high risk of developing type 2 diabetes

  2013cited by this paper
• Practical implications of choice of test in National Institute for Health and Clinical Excellence (NICE) guidance for the prevention of Type 2 diabetes

  2013cited by this paper
• Use of haemoglobin A1c (HbA1c) in the diagnosis of diabetes mellitus. The implementation of World Health Organisation (WHO) guidance 2011

  2012cited by this paper
• Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.

  2012cited by this paper
• Effect of screening for Type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort

  2012cited by this paper
• Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland

  2012cited by this paper
• Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance

  2012cited by this paper
• Should we screen for type 2 diabetes? No

  2012cited by this paper
• Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial

  2012cited by this paper
• Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study

  2012cited by this paper
• Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study

  2012cited by this paper
• Should we screen for type 2 diabetes: Yes

  2012cited by this paper
• The cost of diagnosing Type 2 diabetes mellitus by clinical opportunistic screening in general practice

  2012cited by this paper
• HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).

  2011cited by this paper
• Incidence of Type 2 Diabetes Using Proposed HbA1c Diagnostic Criteria in the European Prospective Investigation of Cancer–Norfolk Cohort

  2011cited by this paper
• Screening for Type 2 diabetes. Lessons from the ADDITION‐Europe study

  2011cited by this paper
• Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention

  2011cited by this paper
• Conference on ‘ Nutrition and health : cell to community ’ Plenary Lecture Nutrition in an ethnically diverse society : what are some of the key challenges ?

  2011cited by this paper
• FINDRISK Questionnaire Combined with HbA1c Testing as a Potential Screening Strategy for Undiagnosed Diabetes in a Healthy Population

  2011influential reference
• Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening

  2011cited by this paper
• Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

  2011influential reference
• HbA1c in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study

  2011cited by this paper
• External validation of QDSCORE® for predicting the 10‐year risk of developing Type 2 diabetes

  2011cited by this paper
• Relative utility of 1-h Oral Glucose Tolerance Test as a measure of abnormal glucose homeostasis.

  2011cited by this paper
• Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk

  2011cited by this paper
• HbA1c measurement for the diagnosis of diabetes: is it enough?

  2011cited by this paper
• Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

  2011influential reference
• Role of glycated hemoglobin in the prediction of future risk of T2DM.

  2011cited by this paper
• Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study

  2011influential reference
• Diagnostic Value of Hemoglobin A1c for Type 2 Diabetes Mellitus in a Population at Risk

  2011cited by this paper
• Risk models and scores for type 2 diabetes: systematic review

  2011influential reference
• Fasting Plasma Glucose and Hemoglobin A1c in Identifying and Predicting Diabetes

  2011cited by this paper
• Haemoglobin A1c towards global standardization

  2010cited by this paper
• A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes

  2010cited by this paper
• Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c.

  2010cited by this paper
• A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors

  2010cited by this paper
• Screening Adults for Pre-Diabetes and Diabetes May Be Cost-Saving

  2010cited by this paper
• Impact of A1C Screening Criterion on the Diagnosis of Pre-Diabetes Among U.S. Adults

  2010cited by this paper
• Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1cThe Danish Inter99 study

  2010cited by this paper
• Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany

  2010cited by this paper
• The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus

  2010cited by this paper
• Performance of existing risk scores in screening for undiagnosed diabetes: an external validation study

  2010cited by this paper
• HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark

  2010cited by this paper
• A1C to Detect Diabetes in Healthy Adults

  2010cited by this paper
• ABCD position statement on haemoglobin A1c for the diagnosis of diabetes

  2010cited by this paper
• Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

  2010cited by this paper
• Cardiovascular Disease Mortality in Europeans in Relation to Fasting and 2-h Plasma Glucose Levels Within a Normoglycemic Range

  2010cited by this paper
• Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance

  2010cited by this paper
• The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study

  2010cited by this paper
• Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis.

  2010cited by this paper
• Markers of Dysglycaemia and Risk of Coronary Heart Disease in People without Diabetes: Reykjavik Prospective Study and Systematic Review

  2010cited by this paper
• Screening for Diabetes and Pre-Diabetes With Proposed A1C-Based Diagnostic Criteria

  2010cited by this paper
• Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

  2010cited by this paper
• A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.

  2010cited by this paper
• Postchallenge Glucose, A1C, and Fasting Glucose as Predictors of Type 2 Diabetes and Cardiovascular Disease

  2010cited by this paper
• Glycemic Thresholds for Diabetes-Specific Retinopathy

  2010cited by this paper
• Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

  2010cited by this paper
• Glycated haemoglobin A1c (HbA1c) in the diagnosis of diabetes mellitus: don’t forget the performance of the HbA1c assay

  2010cited by this paper
• Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study

  2010cited by this paper
• Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care

  2010cited by this paper
• Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey

  2010cited by this paper
• Ethnic differences in glycated haemoglobin between white subjects and those of South Asian origin with normal glucose tolerance

  2010cited by this paper
• Diabetes: Glycated hemoglobin is a marker of diabetes and CVD risk

  2010cited by this paper
• Glucose challenge test screening for prediabetes and undiagnosed diabetes

  2009cited by this paper
• International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

  2009cited by this paper
• A1C Is Associated With Intima-Media Thickness in Individuals With Normal Glucose Tolerance

  2009cited by this paper
• Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes

  2009cited by this paper
• Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial

  2009cited by this paper
• Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore

  2009cited by this paper
• Abstract 1445: The Association of Hemoglobin A1c With Incident Heart Failure Among Persons Without Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

  2009cited by this paper
• Relationship between glycated haemoglobin and microvascular complications: Is there a natural cut-off point for the diagnosis of diabetes?

  2009cited by this paper
• Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study

  2009influential reference
• Comparison of A1C and Fasting Glucose Criteria to Diagnose Diabetes Among U.S. Adults

  2009cited by this paper
• Cardiovascular risk assessment scores for people with diabetes: a systematic review

  2009influential reference
• Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study.

  2009cited by this paper
• Undiagnosed diabetes—data from the English longitudinal study of ageing

  2009cited by this paper
• Evaluating the impact of a national pilot screening programme for type 2 diabetes in deprived areas of England.

  2008cited by this paper
• A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study.

  2008cited by this paper
• Diagnosing Type 2 diabetes before patients complain of diabetic symptoms—clinical opportunistic screening in a single general practice

  2008cited by this paper
• Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis

  2008cited by this paper
• Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study

  2008influential reference
• Is relative mortality of type 2 diabetes mellitus decreasing?

  2008cited by this paper
• Ethnic diversity in Type 2 diabetes

  2008cited by this paper
• Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• How much might cardiovascular disease risk be reduced by intensive therapy in people with screen‐detected diabetes?

  2008influential reference
• Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults

  2008cited by this paper
• Using an economic model of diabetes to evaluate prevention and care strategies in Australia.

  2008cited by this paper
• Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program

  2007cited by this paper
• HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.

  2007cited by this paper
• Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

  2007cited by this paper
• HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review

  2007cited by this paper
• Type 2 Diabetes Prevention in the Real World

  2007cited by this paper
• Noninvasive Type 2 Diabetes Screening

  2007cited by this paper
• Screening for type 2 diabetes: literature review and economic modelling.

  2007influential reference
• The prevalence of retinopathy in impaired glucose tolerance and recent‐onset diabetes in the Diabetes Prevention Program

  2007cited by this paper
• A Simplified Finnish Diabetes Risk Score to Predict Type 2 Diabetes Risk and Disease Evolution in a German Population

  2007cited by this paper
• Patients' experiences of screening for type 2 diabetes: prospective qualitative study embedded in the ADDITION (Cambridge) randomised controlled trial

  2007cited by this paper

• Potential Biomarkers of Carbohydrate Metabolism Disorders: A Pilot Study

  2025cites this paper
• Improving Diabetes and Pre-Diabetes Detection in the UK: Insights From HbA1c Screening in an Acute Hospital’s Emergency Department

  2025cites this paper
• Comparative study of fecal calprotectin levels in ulcerative colitis versus irritable bowel syndrome

  2025cites this paper
• Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case–control study

  2024cites this paper
• Missed Opportunities in Type 2 Diabetes Mellitus: A Narrative Review.

  2024cites this paper
• ‘Assessing patients’ perception of the potential utility of visual function home monitoring app among patients with diabetes in Saudi Arabia’

  2024cites this paper
• Protective properties of Ophiopogonin D in DSS-induced colitis: insights into microbiota modulation

  2024cites this paper
• Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn’s Disease and Ulcerative Colitis

  2024cites this paper
• Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation.

  2024cites this paper
• A practical evidence-based approach to management of type 2 diabetes in children and young people (CYP): UK consensus

  2024cites this paper
• Detección de personas en riesgo de padecer diabetes en la farmacia comunitaria con el test de Findrisc en los años 2014-2021

  2023cites this paper
• A novel kernel based approach to arbitrary length symbolic data with application to type 2 diabetes risk

  2022cites this paper
• Ethnic differences in cardiovascular risk: examining differential exposure and susceptibility to risk factors

  2022cites this paper
• LEP G2548A polymorphism is associated with increased serum leptin and insulin resistance among T2DM Malaysian patients

  2022cites this paper
• Efficacy of an Online Educational Intervention in Reducing Body Weight in the Pre-Diabetic Population of 18–45 Years Old, a Randomized Trial Protocol

  2022cites this paper
• Examining Social Determinants of Undiagnosed Diabetes in Namibia and South Africa Using a Behavioral Model of Health Services Use.

  2021cites this paper
• Role of Branched Chain Amino Acid and Glycine in Prediabetes and Type II Diabetes Mellitus

  2021cites this paper
• Time trends in the incidence of clinically diagnosed type 2 diabetes and pre-diabetes in the UK 2009–2018: a retrospective cohort study

  2021cites this paper
• Beneficial effects of whole-body cryotherapy on glucose homeostasis and amino acid profile are associated with a reduced myostatin serum concentration

  2021cites this paper
• Nurse-led development of a rapid-access clinic and referral pathway for suspected inflammatory bowel disease

  2021cites this paper
• Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients

  2021cites this paper
• Effects of High-Intensity Interval Training on Inflammatory Biomarkers in Patients with Type 2 Diabetes. A Systematic Review

  2021cites this paper
• Discordance between fasting plasma glucose and A1c in the diagnosis and management of diabetes

  2021cites this paper
• Methods for evaluating the benefits and harms of antenatal and newborn screening programmes adopted by health economic assessments: protocol for a systematic review

  2021cites this paper
• Screening for Diabetes and Prediabetes.

  2021cites this paper
• Modification of cardiovascular disease risk by health behaviour change following type 2 diabetes diagnosis

  2021cites this paper
• The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.

  2020cites this paper
• Screening strategies for adults with type 2 diabetes mellitus: a systematic review protocol

  2020cites this paper
• Prevalence of Undiagnosed Diabetes and Prediabetes in the Dental Setting: A Systematic Review and Meta-Analysis

  2020cites this paper
• Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy

  2020cites this paper
• Screening for type 2 diabetes mellitus.

  2020cites this paper
• A positive diagnostic strategy is safe and saves endoscopies in patients with irritable bowel syndrome: A five‐year follow‐up of a randomized controlled trial

  2020cites this paper
• Risk Assessment for Diabetes

  2020cites this paper
• Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting

  2020cites this paper
• Screening auf Typ-2-Diabetes

  2020influential citation
• Use of dental practices for the identification of adults with undiagnosed type 2 diabetes mellitus or non‐diabetic hyperglycaemia: a systematic review

  2020cites this paper
• Evaluation of the Diabetes Screening Component of a National Cardiovascular Risk Assessment Programme in England: a Retrospective Cohort Study

  2020cites this paper
• Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype

  2020cites this paper
• Epidemiology of spinal cord and column tumors.

  2020cites this paper
• The added value of periodontal measurements for identification of diabetes among Saudi adults.

  2020cites this paper
• Intrauterine Programming of Diabetes Induced Cardiac Embryopathy.

  2019cites this paper
• LSHTM Research Online

  2019cites this paper
• The Clinical Accuracy of the BÜHLMANN fCAL ELISA in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Multicenter Prospective Case–Control Study

  2019cites this paper
• Can the CalproQuest predict a positive Calprotectin test? A prospective diagnostic study

  2019cites this paper
• A Comparison of biomarkers in assessment of glycemic control in diabetes: Reviewing the Evidence.

  2019cites this paper
• Associations of food groups and cardiometabolic and inflammatory biomarkers - does the meal matter?

  2019cites this paper
• Prediabetes Risk Assessment among Nurses Recruited in a Dubai Local Government Hospital: A Cross-Sectional Study

  2019cites this paper
• Verpasste Chance — die Überarbeitung der GU-Richtlinie aus Sicht der DEGAM

  2019cites this paper
• LSHTM Research Online

  2019cites this paper
• Screening for Diabetes and Prediabetes

  2018cites this paper
• Integrating Medical-Dental Care for Diabetic Patients: Qualitative Assessment of Provider Perspectives

  2018cites this paper
• Sexual functioning and depressive symptoms in women with various types of prediabetes - a pilot study.

  2018cites this paper
• FINDRISC, UTILITY IN THE SCREENING OF DIABETES, PERSONALIZATION AND ASSOCIATIONS

  2018cites this paper
• Blood-free risk scores and neuropathy assessment tools to detect undiagnosed type 2 diabetes in Peru.

  2018cites this paper
• Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study

  2018cites this paper
• Reprint of: Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention: JACC Health Promotion Series.

  2018cites this paper
• Prognosis of Single Spinal Metastatic Tumors: Predictive Value of the Spinal Instability Neoplastic Score System for Spinal Adverse Events

  2018cites this paper
• How do we identify people at high risk of Type 2 diabetes and help prevent the condition from developing?

  2018cites this paper
• Prevention of type 2 diabetes: what is the right target population?

  2018influential citation
• NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation

  2018cites this paper
• Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention: JACC Health Promotion Series.

  2018cites this paper
• Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes

  2018cites this paper
• Screening for dysglycaemia in dental primary care practice settings: systematic review of the evidence.

  2018cites this paper
• A double‐blind, placebo‐controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea‐predominant IBS

  2017cites this paper
• Validation of the diabetes screening tools proposed by the American Diabetes Association in an aging Chinese population

  2017cites this paper
• Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation

  2017cites this paper
• Status Update on Translation of Integrated Primary Dental-Medical Care Delivery for Management of Diabetic Patients

  2017cites this paper
• Calprotectin in Daily Practice: Where Do We Stand in 2017?

  2017cites this paper
• Validity, Usefulness and Cost of RETeval System for Diabetic Retinopathy Screening

  2017cites this paper
• Finnish Diabetic Risk Score: A Tool for Predicting Risk of Undiagnosed Type 2 Diabetes Mellitus

  2017cites this paper
• Effects of hyperbaric factors on lidocaine-induced apoptosis in spinal neurons and the role of p38 mitogen-activated protein kinase in rats with diabetic neuropathic pain

  2017influential citation
• Transculturalizing Diabetes Prevention in Latin America.

  2017cites this paper
• Should we screen for type 2 diabetes among asymptomatic individuals? Yes

  2017cites this paper
• Predictive Value of the Water Drinking Test and the Risk of Glaucomatous Visual Field Progression

  2017cites this paper
• Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease.

  2017cites this paper
• Proteomics and irritable bowel syndrome

  2017cites this paper
• Diagnosis and screening

  2017cites this paper
• Associations between community-based physiotherapy for musculoskeletal injury and health related quality of life (EQ-5D): a multi-centre retrospective analysis

  2017cites this paper
• Utilização do FINDRISC no Rastreio da Diabetes em Utentes Assintomáticos

  2017cites this paper
• The importance of calprotectin for differentiating organic inflammatory disease and avoiding unnecessary procedures in paediatrics.

  2017cites this paper
• Systematic literature review of the health economic implications of early detection by screening populations at risk for type 2 diabetes

  2017cites this paper
• Fecal neutrophil gelatinase‐associated lipocalin as a biomarker for inflammatory bowel disease

  2017cites this paper
• Screen and intervene to prevent diabetes?

  2017cites this paper
• Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease

  2017cites this paper
• The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation.

  2016cites this paper
• Immunoanalytical characteristics of fecal calprotectin.

  2016cites this paper
• The Joint-Gut Axis Exploring the Orthopaedic and Rheumatologic Manifestations of Inflammatory Bowel Disease.

  2016cites this paper
• The use of glucose measurements to improve screening for diabetes in clinical practice

  2016cites this paper
• Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives.

  2016cites this paper
• Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated?

  2016cites this paper
• Mortality and cardiovascular disease outcomes among 740 patients with new‐onset Type 2 diabetes detected by screening or clinically diagnosed in general practice

  2016cites this paper
• Elevated fecal calprotectin levels during necrotizing enterocolitis are associated with activated neutrophils extruding neutrophil extracellular traps

  2016cites this paper
• Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats

  2016cites this paper
• Prevention and Screening for Type 2 Diabetes Newfoundland and Labrador

  2016influential citation
• Variations in the Obesity Gene “LEPR” Contribute to Risk of Type 2 Diabetes Mellitus: Evidence from a Meta-Analysis

  2016cites this paper
• Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study

  2016cites this paper
• Implementation of a prediabetes identification algorithm for overweight and obese Veterans.

  2016cites this paper
• Optimal Glycemic and Hemoglobin A1c Thresholds for Diagnosing Diabetes Based on Prevalence of Retinopathy in an Iranian Population

  2016cites this paper
• The acceptability to patients of PhysioDirect telephone assessment and advice services; a qualitative interview study

  2016cites this paper
• Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection

  2016cites this paper